Health effects of coffee

Digestion

A 1999 review found that coffee does not cause indigestion, but may promote gastrointestinal reflux. Two reviews of clinical studies on people recovering from abdominal, colorectal, and gynecological surgery found that coffee consumption was safe and effective for enhancing postoperative gastrointestinal function.

In some people, coffee induces defecation within minutes of consumption. However, the specific mechanism of action and chemical constituents responsible are still unknown.

Mortality

A 2014 meta-analysis found that coffee consumption (4 cups/day) was inversely associated with all-cause mortality (a 16% lower risk), as well as cardiovascular disease mortality specifically (a 21% lower risk from drinking 3 cups/day), but not with cancer mortality with exception being oral cancer mortality.

Additional meta-analyses corroborated these findings, showing that higher coffee consumption (2–4 cups per day) was associated with a reduced risk of death by all disease causes.

Cardiovascular disease

Moderate coffee consumption is not a risk factor for coronary heart disease.

A 2012 meta-analysis concluded that people who drank moderate amounts of coffee had a lower rate of heart failure, with the biggest effect found for those who drank more than four cups a day. A 2014 meta-analysis concluded that cardiovascular disease, such as coronary artery disease and stroke, is less likely with three to five cups of non-decaffeinated coffee per day but more likely with over five cups per day. A 2016 meta-analysis showed that coffee consumption was associated with a reduced risk of death in patients who have had a myocardial infarction. The effect of no or moderate daily consumption of coffee on risk for developing hypertension has been assessed in several reviews during the 21st century. A 2019 review found that one to two cups consumed per day did not affect hypertension risk, whereas drinking three or more cups per day reduced the risk, a finding in agreement with a 2017 analysis which showed a 9% lower risk of hypertension with long-term consumption of up to seven cups of coffee per day. Another review in 2018 found that the risk of hypertension was reduced by 2% with each cup per day increment of coffee consumption up to 8 cups per day, compared with people who did not consume any coffee.

A large 2024 study, involving close to two hundred thousand participants using the UK Biobank, indicated that a habitual caffeine intake, at moderate levels of 200 mg – 300 mg of caffeine per day "was associated with a lower risk of new-onset CM [Cardiometabolic multimorbidity] and could play important roles in almost all transition phases of CM development." In particular, the study found that metabolites related to very low-density lipoproteins were reduced with higher metabolites related to high-density lipoproteins. The study found any caffeine intake, in general, reduced the risks of CM, although it did not find strong evidence that tea reduced the risk of stroke and Type 2 Diabetes.

By contrast, a 2011 review found that drinking one to three cups of coffee per day may pose a slightly increased risk of developing hypertension.

The 2021 European Society of Cardiology Guidelines on Cardiovascular Disease Prevention in Clinical Practice state: "Non-filtered coffee contains LDL-C-raising cafestol and kahweol, and may be associated with an up to 25% increased risk of atherosclerosis (ASCVD) mortality by consumption of nine or more drinks a day. Non-filtered coffee includes boiled, Greek, and Turkish coffee and some espresso coffees. Moderate coffee consumption (3–4 cups per day) is probably not harmful, perhaps even moderately beneficial".

Parkinson's disease

Meta-analyses have consistently found that long-term coffee consumption is associated with a lower risk of Parkinson's disease.

Type II diabetes

In a systematic review and meta-analysis of 28 prospective observational studies, representing over one million participants, every additional cup of caffeinated and decaffeinated coffee consumed in a day was associated, respectively, with a 9% and 6% lower risk of type 2 diabetes.

Cancer

Meta-analyses on the effects of coffee consumption on cancer risk are inconclusive.

The World Health Organization's 2016 IARC Monograph "found no conclusive evidence for a carcinogenic effect of drinking coffee" but found that drinking very hot beverages probably causes cancer of the oesophagus.

Liver disease

According to The British Liver Trust, regular consumption of coffee may support liver health and reduce the risk of some liver diseases.

Mental health

The UK National Health Service advises that avoiding coffee may reduce anxiety. In chronic psychiatric patients, caffeine, the major active ingredient in coffee, is associated with anxiety. At high doses, typically greater than 300 mg, caffeine can both cause and worsen anxiety. For some people, discontinuing caffeine use can significantly reduce anxiety. Caffeine-induced anxiety disorder is a subclass of substance- or medication-induced anxiety disorder. Populations that may be most impacted by caffeine consumption are adolescents and people with anxiety disorders. Preliminary research indicated the possibility of a beneficial relationship between coffee intake and reduced depression. Long-term preliminary research, including assessment of symptoms for dementia and cognitive impairment, was inconclusive for coffee having an effect in the elderly, mainly due to the poor quality of the studies.

References

References

1. (2024). "Coffee and the liver". The British Liver Trust.
2. (2016-06-15). "IARC Monographs evaluate drinking coffee, maté, and very hot beverages".
3. (2024-09-17). "Habitual Coffee, Tea, and Caffeine Consumption, Circulating Metabolites, and the Risk of Cardiometabolic Multimorbidity". The Journal of Clinical Endocrinology & Metabolism.
4. (2024-06-08). "Coffee - Brewing, Roasting, Varieties".
5. (2017-11-22). "Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes". [[BMJ]].
6. (1999-07-08). "Coffee and gastrointestinal function: facts and fiction. A review". [[Scandinavian Journal of Gastroenterology. Supplement]].
7. (May 2020). "Coffee to go? The effect of coffee on resolution of ileus following abdominal surgery: A systematic review and meta-analysis of randomised controlled trials". Clinical Nutrition.
8. (2018-11-26). "Effect of postoperative coffee consumption on gastrointestinal function after abdominal surgery: A systematic review and meta-analysis of randomized controlled trials". [[Scientific Reports]].
9. (2005). "Stimulation of defecation: Effects of coffee use and nicotine on rectal tone and visceral sensitivity". [[Scandinavian Journal of Gastroenterology]].
10. (November 2015). "Effect of Coffee on the Length of Postoperative Ileus After Elective Laparoscopic Left-Sided Colectomy". [[Diseases of the Colon & Rectum]].
11. (2022-01-17). "Effects of Coffee on the Gastro-Intestinal Tract: A Narrative Review and Literature Update". [[Nutrients (journal).
12. (2023-08-18). "Why Does Coffee Make You Poop?".
13. (2014-10-15). "Coffee Consumption and Mortality From All Causes, Cardiovascular Disease, and Cancer: A Dose-Response Meta-Analysis". [[American Journal of Epidemiology]].
14. (2013-01-01). "Coffee, Tea, and Fatal Oral/Pharyngeal Cancer in a Large Prospective US Cohort". [[American Journal of Epidemiology]].
15. (2014-04-14). "Coffee consumption and total mortality: a meta-analysis of twenty prospective cohort studies". [[Cambridge University Press]].
16. (May 2015). "Association of coffee drinking with all-cause mortality: a systematic review and meta-analysis". [[Cambridge University Press]].
17. (November 2009). "Coffee consumption and risk of coronary heart diseases: a meta-analysis of 21 prospective cohort studies". [[International Journal of Cardiology]].
18. (July 2012). "Habitual Coffee Consumption and Risk of Heart Failure: A Dose-Response Meta-Analysis". [[Circulation: Heart Failure]].
19. (February 2014). "Long-Term Coffee Consumption and Risk of Cardiovascular Disease: A Systematic Review and a Dose–Response Meta-Analysis of Prospective Cohort Studies". [[Circulation (journal).
20. (November 2016). "Coffee reduces the risk of death after acute myocardial infarction: a meta-analysis". Coronary Artery Disease.
21. (February 2019). "Coffee consumption and risk of hypertension: a dose-response meta-analysis of prospective studies". [[European Journal of Nutrition]].
22. (2017-08-17). "Long-Term Coffee Consumption Is Associated with Decreased Incidence of New-Onset Hypertension: A Dose-Response Meta-Analysis". [[Nutrients (journal).
23. (February 2018). "Coffee consumption and risk of hypertension: a systematic review and dose-response meta-analysis of cohort studies". [[Journal of Human Hypertension]].
24. (June 2011). "Habitual coffee consumption and risk of hypertension: a systematic review and meta-analysis of prospective observational studies". [[The American Journal of Clinical Nutrition]].
25. (2021-09-07). "2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)". [[European Heart Journal]].
26. (2014-01-11). "Caffeinated and Decaffeinated Coffee Consumption and Risk of Type 2 Diabetes: A Systematic Review and a Dose-Response Meta-analysis". [[Diabetes Care]].
27. (2016-08-02). "Coffee drinking and colorectal cancer risk: an evaluation based on a systematic review and meta-analysis among the Japanese population". [[Japanese Journal of Clinical Oncology]].
28. (2017-09-01). "Coffee and the risk of hepatocellular carcinoma and chronic liver disease: a systematic review and meta-analysis of prospective studies". [[European Journal of Cancer Prevention]].
29. (2020-02-20). "Coffee drinking and cancer risk: an umbrella review of meta-analyses of observational studies". [[BMC Cancer]].
30. (2018-12-19). "Self-help: Generalised anxiety disorder in adults". [[National Health Service]].
31. (2005). "Neuropsychiatric effects of caffeine". [[Cambridge University Press]].
32. (August 2011). "Caffeine challenge test and panic disorder: a systematic literature review". [[Taylor & Francis]].
33. (October 2002). "Effects of caffeine on human behavior". [[Food and Chemical Toxicology]].
34. (February 1989). "Caffeine abstention in the management of anxiety disorders". [[Psychological Medicine]].
35. (September 2014). "Caffeine Use Disorder: A Review of the Evidence and Future Implications". Current Addiction Reports - Addictive Disorders in DSM-5.
36. (May 2016). "Adolescent caffeine consumption increases adulthood anxiety-related behavior and modifies neuroendocrine signaling". [[Psychoneuroendocrinology (journal).
37. (March 2016). "Coffee and caffeine consumption and depression: A meta-analysis of observational studies". [[The Australian and New Zealand Journal of Psychiatry]].
38. (January 2016). "Coffee, tea, caffeine and risk of depression: A systematic review and dose-response meta-analysis of observational studies". [[Molecular Nutrition & Food Research]].
39. (March 2015). "Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: a systematic review". [[The Journal of Nutrition, Health & Aging]].